Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, China

Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), infection has been deemed as a global pandemic by the World Health Organisation. While diffuse alveolar damage (DAD) is recognised to be the primary manifestation of COVID‐19 pneumonia, there has been little emphasis on the progression to the fibrosing phase of DAD. This topic is of great interest, due to growing concerns regarding the potential long‐term complications in prolonged survivors.

[1]  R. Fiocca,et al.  Lung fibrosis: an undervalued finding in COVID-19 pathological series , 2020, The Lancet Infectious Diseases.

[2]  M. Storgaard,et al.  Fatal pulmonary fibrosis: a post-COVID-19 autopsy case , 2020, Journal of Clinical Pathology.

[3]  E. Kocakoç,et al.  Pulmonary Fibrosis Due to COVID-19 Pneumonia , 2020, Korean journal of radiology.

[4]  C. Catalano,et al.  Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis , 2020, European Radiology.

[5]  W. Travis,et al.  Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies , 2020, Histopathology.

[6]  J. van Paassen,et al.  A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression , 2020, Modern Pathology.

[7]  Filippo Cademartiri,et al.  COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead , 2020, European journal of preventive cardiology.

[8]  S. Seifirad Pirfenidone: A novel hypothetical treatment for COVID-19 , 2020, Medical Hypotheses.

[9]  J. Myers,et al.  Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD , 2020, Histopathology.

[10]  H. Su,et al.  [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy]. , 2020, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[11]  Andrea Gianatti,et al.  Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study , 2020, The Lancet Infectious Diseases.

[12]  Kacper Lechowicz,et al.  COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection , 2020, Journal of clinical medicine.

[13]  Hong Yang,et al.  Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge , 2020, Journal of X-ray science and technology.

[14]  M. Dolhnikoff,et al.  Pulmonary and systemic involvement in COVID‐19 patients assessed with ultrasound‐guided minimally invasive autopsy , 2020, Histopathology.

[15]  R. Claus,et al.  Postmortem Examination of Patients With COVID-19. , 2020, JAMA.

[16]  T. Uyeki,et al.  Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States , 2020, Emerging infectious diseases.

[17]  Lina Zhang,et al.  Chest lesion CT radiological features and quantitative analysis in RT-PCR turned negative and clinical symptoms resolved COVID-19 patients. , 2020, Quantitative imaging in medicine and surgery.

[18]  A. Wells,et al.  Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy , 2020, The Lancet Respiratory Medicine.

[19]  J. Chong,et al.  Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan , 2020, Emerging infectious diseases.

[20]  P. Spagnolo,et al.  Pulmonary fibrosis secondary to COVID-19: a call to arms? , 2020, The Lancet Respiratory Medicine.

[21]  M. Trauner,et al.  Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series , 2020, Annals of Internal Medicine.

[22]  M. Aepfelbacher,et al.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.

[23]  Da Teng,et al.  Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia , 2020, European Radiology.

[24]  M. Copin,et al.  Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection , 2020, Intensive Care Medicine.

[25]  Haibo Xu,et al.  Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia , 2020, Korean journal of radiology.

[26]  T. Liang,et al.  Lung Transplantation for Elderly Patients With End-Stage COVID-19 Pneumonia , 2020, Annals of surgery.

[27]  Subha Ghosh,et al.  COVID-19 Autopsies, Oklahoma, USA , 2020, American journal of clinical pathology.

[28]  J. Q. Brown,et al.  Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans , 2020, medRxiv.

[29]  Jianxing He,et al.  Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis , 2020, Chinese medical journal.

[30]  S. Xiao,et al.  Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies , 2020, Modern Pathology.

[31]  N. Yu,et al.  Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019 , 2020, Journal of Pharmaceutical Analysis.

[32]  Carlos Dobkin,et al.  Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality , 2020, Annals of Internal Medicine.

[33]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[34]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[35]  Peixun Zhang,et al.  Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study , 2020, Bone Research.

[36]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[37]  P. Zanotto,et al.  Ultrasound-guided minimally invasive autopsy as a tool for rapid post-mortem diagnosis in the 2018 Sao Paulo yellow fever epidemic: Correlation with conventional autopsy , 2019, PLoS neglected tropical diseases.

[38]  A. Churg,et al.  Cicatricial organising pneumonia mimicking a fibrosing interstitial pneumonia , 2018, Histopathology.

[39]  A. Hajeer,et al.  Histopathology of Middle East respiratory syndrome coronovirus (MERS‐CoV) infection – clinicopathological and ultrastructural study , 2017, Histopathology.

[40]  M. Kitaichi,et al.  A Cryptogenic Case of Fulminant Fibrosing Organizing Pneumonia , 2017, Internal medicine.

[41]  D. Lynch,et al.  American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[42]  A. Nicholson,et al.  Prognostic relevance of histological variants in nonspecific interstitial pneumonia , 2014, Histopathology.

[43]  D. Cummings,et al.  Hospital outbreak of Middle East respiratory syndrome coronavirus. , 2013, The New England journal of medicine.

[44]  D. Rassl,et al.  Fibrosing organising pneumonia , 2013, Journal of Clinical Pathology.

[45]  T. Uyeki,et al.  Immunopathology and Infectious Diseases 2009 Pandemic Influenza A ( H 1 N 1 ) Pathology and Pathogenesis of 100 Fatal Cases in the United States , 2010 .

[46]  D. Mollura,et al.  Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. , 2010, Archives of pathology & laboratory medicine.

[47]  J. Taubenberger,et al.  The pathology of influenza virus infections. , 2008, Annual review of pathology.

[48]  Jiang Gu,et al.  Pathology and Pathogenesis of Severe Acute Respiratory Syndrome , 2007, The American Journal of Pathology.

[49]  F. Martinez,et al.  Nonspecific interstitial pneumonia. , 2006, Seminars in respiratory and critical care medicine.

[50]  S. Asa,et al.  Pulmonary pathology of severe acute respiratory syndrome in Toronto , 2005, Modern Pathology.

[51]  J. Chan,et al.  The spectrum of pathological changes in severe acute respiratory syndrome (SARS) , 2004, Histopathology.

[52]  N. Müller,et al.  Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. , 2004, Radiology.

[53]  J. Sung,et al.  Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) , 2004, Journal of Clinical Pathology.

[54]  J. Sung,et al.  Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. , 2003, Radiology.

[55]  W. Travis,et al.  Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore , 2003, Human Pathology.

[56]  J. Tomashefski Pulmonary pathology of acute respiratory distress syndrome. , 2000, Clinics in chest medicine.

[57]  J. Kucharczyk,et al.  High imaging technology and health care expenditures , 1994, European Radiology.

[58]  A. Katzenstein,et al.  Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance , 1994, The American journal of surgical pathology.

[59]  J. May,et al.  Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. , 1979, Thorax.

[60]  A. Katzenstein,et al.  Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. , 1976, The American journal of pathology.

[61]  E. Goodpasture THE SIGNIFICANCE OF CERTAIN PULMONARY LESIONS IN RELATION TO THE ETIOLOGY OF INFLUENZA , 1919 .

[62]  E. Lecount THE PATHOLOGIC ANATOMY OF INFLUENZAL BRONCHOPNEUMONIA , 1919 .

[63]  S. Simmens,et al.  BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia , 2009, Modern Pathology.

[64]  A. Torres,et al.  Histopathology of ventilator-associated pneumonia (VAP) and its clinical implications , 2007, Infection.

[65]  N. Müller,et al.  High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission. , 2004, AJR. American journal of roentgenology.

[66]  D. Hansell,et al.  Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. , 1999, Radiology.

[67]  Pratt Pc Pathology of adult respiratory distress syndrome. , 1978 .

[68]  P. Pratt Pathology of adult respiratory distress syndrome. , 1978, Monographs in pathology.